Dr Bill Nelson and Dr Michael Desjardins discuss the role geography plays in determining how we approach the treatment of cancer in different communities. To learn more about the Cancer InFocus program, visit cif.jhmi.edu.

Dr Bill Nelson and Dr Mike Carducci examine the latest hormone target therapies for prostate cancer, their side effect profiles and the evolution of individualized treatments.

Dr Akila Viswanathan speaks with Dr Thomas DeLaney from the Dartmouth Cancer Center and Dr Alexander Ruhle from the University of Leipzig Medical Center about an issue of Seminars in Radiation Oncology entitled Functional Radiotherapy for Non-Malignant Diseases: The Potential of Ionizing Radiation Beyond Cancer Treatment.

Dr Bill Nelson and Dr Elizabeth Jaffee discuss two significant breakthroughs in pancreatic cancer. The first is daraxonrasib, a drug that has significantly prolonged survival in patients with metastatic pancreatic cancer and a new vaccine targeting mutations that cause the disease and that could potentially go as far as preventing it altogether.

Dr Bill Nelson talks to thoracic surgeon, Dr Stephen Yang, about the developments in lung cancer surgery that have resulted in more minimally invasive procedures and improved patient outcomes.

Dr Bill Nelson talks with YouTuber and science communicator Hank Green about his diagnosis and treatment for Hodgkin lymphoma, the quickening of advances in cancer therapies and the most likely areas for future care breakthroughs.

May is Melanoma Awareness Month. In this episode, Dr Bill Nelson and Dr Ashani Weeraratna explain the causes of melanoma and what you can do to reduce your risk for skin cancers.

In this episode, we tackle a critical and often unsettling subject of the history of racial ethics in healthcare. This discussion is not just about looking back at the past, but about understanding how historical injustices continue to influence present-day healthcare practices and perceptions. The history of racial ethics in healthcare is complex and fraught with ethical breaches that have left deep scars in communities, particularly among African Americans. Perhaps one of the most infamous examples is the Tuskegee Syphilis Study. Conducted between 1932 and 1972, this study involved hundreds of African American men who were misled and denied proper treatment for syphilis. This egregious violation of ethical standards was justified at the time by prevailing racist ideologies that dehumanized Black individuals and viewed them as suitable subjects for experimentation.

Dr Otis Brawley sheds light on the often-confusing world of cancer statistics by explaining the crucial differences between survival rates and death rates. He delves into how increased survival rates can paradoxically correlate with higher mortality rates and the factors that contribute to this complex relationship. Dr Brawley addresses common misconceptions about cancer statistics and offers practical advice for healthcare professionals on effectively communicating these nuances to patients. The episode also highlights the potential pitfalls of using survival rates as the sole metric for treatment success, the role of early detection in shaping public perception, and the importance of responsible media reporting.